Your browser doesn't support javascript.
loading
Immunogenicity Evaluating of the Multivalent COVID-19 Inactivated Vaccine against the SARS-CoV-2 Variants.
Zhang, Yuntao; Tan, Wenjie; Lou, Zhiyong; Huang, Baoying; Zhou, Weimin; Zhao, Yuxiu; Zhang, Jin; Liang, Hongyang; Li, Na; Zhu, Xiujuan; Ding, Ling; Guo, Yancen; He, Zhenyu; He, Yao; Wang, Zhanhui; Ma, Bo; Ma, Meng; Zhao, Suhua; Chang, Zhen; Zhao, Xue; Zheng, Xiaotong; Wu, Guizhen; Wang, Hui; Yang, Xiaoming.
Afiliação
  • Zhang Y; China National Biotec Group Company Limited, Beijing 100024, China.
  • Tan W; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing 102206, China.
  • Lou Z; MOE Key Laboratory of Protein Science & Collaborative Innovation Center of Biotherapy, School of Medicine, Tsinghua University, Beijing 100084, China.
  • Huang B; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing 102206, China.
  • Zhou W; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing 102206, China.
  • Zhao Y; Beijing Institute of Biological Products Company Limited, Beijing 100176, China.
  • Zhang J; Beijing Institute of Biological Products Company Limited, Beijing 100176, China.
  • Liang H; Beijing Institute of Biological Products Company Limited, Beijing 100176, China.
  • Li N; Beijing Institute of Biological Products Company Limited, Beijing 100176, China.
  • Zhu X; Beijing Institute of Biological Products Company Limited, Beijing 100176, China.
  • Ding L; Beijing Institute of Biological Products Company Limited, Beijing 100176, China.
  • Guo Y; Beijing Institute of Biological Products Company Limited, Beijing 100176, China.
  • He Z; Beijing Institute of Biological Products Company Limited, Beijing 100176, China.
  • He Y; Beijing Institute of Biological Products Company Limited, Beijing 100176, China.
  • Wang Z; Beijing Institute of Biological Products Company Limited, Beijing 100176, China.
  • Ma B; Beijing Institute of Biological Products Company Limited, Beijing 100176, China.
  • Ma M; Beijing Institute of Biological Products Company Limited, Beijing 100176, China.
  • Zhao S; Beijing Institute of Biological Products Company Limited, Beijing 100176, China.
  • Chang Z; Beijing Institute of Biological Products Company Limited, Beijing 100176, China.
  • Zhao X; Beijing Institute of Biological Products Company Limited, Beijing 100176, China.
  • Zheng X; Beijing Institute of Biological Products Company Limited, Beijing 100176, China.
  • Wu G; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing 102206, China.
  • Wang H; Beijing Institute of Biological Products Company Limited, Beijing 100176, China.
  • Yang X; China National Biotec Group Company Limited, Beijing 100024, China.
Vaccines (Basel) ; 10(6)2022 Jun 16.
Article em En | MEDLINE | ID: mdl-35746564
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Vaccines (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Vaccines (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China